NASDAQ$ACB

Aurora Cannabis Inc · Q1 2026 earnings

Q1 2026 earnings · · Investor relations

Briefing

Aurora Cannabis Q1 FY2026: $98M revenue (+17%), adjusted EBITDA $10.8M

Aurora Cannabis reported first quarter fiscal 2026 (three months ended June 30, 2025) net revenue of $98.0 million, up 17% year over year, driven by 37% growth in medical cannabis to $64.8 million and 74% growth in plant propagation (Bevo) to $23.9 million, partially offset by a 32% decline in consumer cannabis. The company posted a net loss from continuing operations of $19.4 million ($0.26 per share) compared to net income of $3.5 million in the prior-year quarter. Adjusted EBITDA was $10.8 million versus $3.5 million a year ago. Adjusted gross margin on total net revenue was 52%. Free cash flow was $9.2 million. Working capital stood at $308.4 million.

  • Net revenue $98.0M (+17% YoY); medical cannabis $64.8M (+37%) led growth.
  • Adjusted EBITDA $10.8M (+209% YoY) despite net loss of $19.4M from continuing ops.
  • Consumer cannabis revenue declined 32% to $7.9M; plant propagation (Bevo) up 74% to $23.9M.
  • Free cash flow $9.2M; working capital $308.4M.
  • Subsequent EU-GMP certification for Brampton distribution centre to support international medical markets.

Headline financials

Total Revenue

C$98M

No prior period
EPS (adj)

-C$0.26

No prior period
Adjusted EBITDA

C$10.8M

No prior period
Adjusted gross margin

52.0%

No prior period
Free cash flow

C$9.23M

No prior period
Capital Expenditures

-C$3.64M

No prior period
Net Income

-C$19.4M

No prior period
Gross Profit

C$28M

No prior period
R&D Expense

C$860K

No prior period

Revenue & EPS history

Aurora Cannabis · Revenue · Quarterly

C$98M

Q1 2026
Beat estimate in 5 of 13 quarters(38%)
ActualEstimate

Revenue by segment

Aurora Cannabis · C$96.6M total across 3 segments · Q1 2026

  • Medical cannabis
    C$64.8M
  • Plant propagation (Bevo)
    C$23.9M
  • Consumer cannabis
    C$7.88M

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q1 2026

Historical avgQ1 2026

+0.5%

Avg return

Earnings day

+2.9%

Avg return

5 days after

-2.8%

Avg return

30 days after

35%

15 / 43 earnings

Positive

+93.1%

Q3 2020

Best reaction

-34.0%

Q2 2021

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2026-5.8%-8.3%
Q2 2026-4.1%+2.9%+1.3%
Q2 2025-16.7%-21.8%-26.5%
Q4 2023+0.4%+4.3%+27.1%
Q1 2026-11.0%-17.7%+0.5%
Q3 2024+9.6%-1.0%-19.7%
Q2 2024+0.4%-0.6%+10.4%
Q1 2024+0.8%-0.9%+0.2%
Q3 2023-9.2%-7.8%-8.9%
Q2 2023-7.2%-5.4%-24.9%
Q1 2023+26.4%+27.3%-6.6%
Q4 2022-11.6%-18.4%-25.9%
Q3 2022+24.0%+34.9%-38.9%
Q2 2022-3.2%-0.2%-31.7%
Q1 2022-2.7%+16.4%-14.0%
Q4 2021+14.5%+19.0%+15.0%
Q3 2021-11.0%-4.3%+27.4%
Q2 2021-34.0%-25.5%-44.1%
Q1 2021-15.2%-27.7%+0.9%
Q4 2020-18.2%-20.1%-23.3%
Q3 2020+93.1%+152.6%+127.8%
Q2 2020+8.2%+12.3%-47.3%
Q1 2020-23.1%-34.1%-25.9%
Q4 2019-6.2%-13.2%-41.4%
Q3 2019+8.2%+8.2%-5.6%
Q2 2019-5.5%-7.1%+19.5%
Q1 2019-8.1%-12.2%-16.0%
Q4 2018-0.9%+8.8%-15.9%
Q3 2018-0.9%+0.3%+18.2%
Q2 2018+1.3%-0.2%-0.2%
Q1 2018+19.4%+63.6%+79.2%
Q4 2017-2.4%-3.0%-2.6%
Q3 2017+2.2%+1.7%-11.0%
Q2 2017-3.5%-3.5%-2.1%
Q1 2017-1.7%-10.8%-16.5%
Q4 2016+1.8%-2.6%+22.3%
Q3 2016-2.9%
Q2 2015-0.1%
Q1 2015+16.0%
Q4 2015-0.2%
Q3 2014+0.0%
Q2 2014+0.0%
Q1 2014+0.0%
Q4 2013
Q3 2013
Q2 2013
Q1 2013
Q4 2012
Q3 2012
Q2 2012
Q1 2012
Q4 2011
Q3 2011
Q2 2011
Q1 2011
Q4 2010
Q3 2010
Q2 2010
Q1 2010
Q4 2009
Q3 2009

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro